2367

Giant Biogene Holding SEHK:2367 Stock Report

Last Price

HK$40.55

Market Cap

HK$39.6b

7D

5.3%

1Y

n/a

Updated

28 Jan, 2023

Data

Company Financials +

Giant Biogene Holding Co., Ltd.

SEHK:2367 Stock Report

Mkt Cap: HK$39.6b

2367 Stock Overview

Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People’s Republic of China.

2367 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth6/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Rewards

Earnings are forecast to grow 27.36% per year

Revenue grew by 30.4% over the past year

Risk Analysis

No risks detected for 2367 from our risk checks.

My Notes

New

Notes are coming soon

Giant Biogene Holding Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Giant Biogene Holding
Historical stock prices
Current Share PriceHK$40.55
52 Week HighHK$41.40
52 Week LowHK$24.30
Beta0
1 Month Change26.72%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO51.87%

Recent News & Updates

Recent updates

Shareholder Returns

2367HK Personal ProductsHK Market
7D5.3%1.0%2.7%
1Yn/a-12.3%-6.2%

Return vs Industry: Insufficient data to determine how 2367 performed against the Hong Kong Personal Products industry.

Return vs Market: Insufficient data to determine how 2367 performed against the Hong Kong Market.

Price Volatility

Is 2367's price volatile compared to industry and market?
2367 volatility
2367 Average Weekly Movement9.9%
Personal Products Industry Average Movement8.7%
Market Average Movement7.8%
10% most volatile stocks in HK Market15.6%
10% least volatile stocks in HK Market3.9%

Stable Share Price: 2367 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: Insufficient data to determine 2367's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000838Jianya Yanhttps://www.xajuzi.com

Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People’s Republic of China. It also manufactures rare ginsenosides technology-based functional foods; and offers medical devices. The company offers its functional skincare products, medical dressings, and functional foods primarily under the Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan brands.

Giant Biogene Holding Co., Ltd. Fundamentals Summary

How do Giant Biogene Holding's earnings and revenue compare to its market cap?
2367 fundamental statistics
Market CapHK$39.58b
Earnings (TTM)HK$933.44m
Revenue (TTM)HK$1.79b

42.4x

P/E Ratio

22.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
2367 income statement (TTM)
RevenueCN¥1.55b
Cost of RevenueCN¥198.15m
Gross ProfitCN¥1.35b
Other ExpensesCN¥545.53m
EarningsCN¥808.81m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.83
Gross Margin87.24%
Net Profit Margin52.10%
Debt/Equity Ratio0%

How did 2367 perform over the long term?

See historical performance and comparison